Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Misop Han"'
Autor:
Michael A. Gorin, Michael H. Johnson, Zeyad Schwen, Misop Han, Trinity J. Bivalacqua, Hiten D. Patel, Mohamad E. Allaf, Alan W. Partin, H. Ballentine Carter, Farzana A. Faisal, Phillip M. Pierorazio, Christian P. Pavlovich, Gregory Joice, Bruce J. Trock
Publikováno v:
European Urology. 78:360-368
Background Direct high-quality evidence is lacking evaluating perioperative pharmacologic prophylaxis (PP) after radical prostatectomy (RP) to prevent venous thromboembolism (VTE) leading to significant practice variation. Objective To study the impa
Autor:
Hiten D. Patel, Zeyad Schwen, Misop Han, Amin S. Herati, Arnav Srivastava, Neil D. Patel, Gregory Joice, Mohamad E. Allaf, Wesley W. Ludwig, Farzana A. Faisal
Publikováno v:
European Urology. 75:215-218
Opioid pain medications are overprescribed, but few data are available to help in appropriate tailoring of postdischarge opioid prescriptions after surgery. Prior studies are retrospective and based on incomplete responses ( 80% of patients and compa
Autor:
Elizabeth B. Humphreys, Bruce J. Trock, Won Sik Ham, Misop Han, Zhaoyong Feng, Heather J. Chalfin, Alan W. Partin, Carling Cheung, Jonathan I. Epstein
Publikováno v:
European Urology. 71:907-912
Background The newly proposed five-tiered prostate cancer grading system (PCGS) divides Gleason score (GS) 8–10 disease into GS 8 and GS 9–10 on the basis of biochemical recurrence (BCR) following radical prostatectomy (RP) as an outcome. However
Autor:
Angelo M. De Marzo, Misop Han, Elizabeth B. Humphreys, Fawaz Almutairi, Ashley E. Ross, Jessica Hicks, Stephanie Glavaris, Edward M. Schaeffer, Tamara L. Lotan, Debasish Sundi, Carlos L. Morais, Jeffrey J. Tosoian, Bruce J. Trock, Scott A. Tomlins
Publikováno v:
European Urology. 71:697-700
African-American (AA) men have a higher risk of lethal prostate cancer (PCa) compared to European-American (EA) men. However, the molecular basis of this difference, if any, remains unclear. In EA PCa, PTEN loss, but not ERG rearrangement, has been a
Autor:
Jonathan I. Epstein, Cristina Magi-Galluzzi, Peter Wiklund, James A. Eastham, Victor E. Reuter, Anil V. Parwani, Michael J. Zelefsky, Jay P. Ciezki, Tommy Nyberg, Joel B. Nelson, Andrew J. Vickers, Daniel Sjöberg, Eric A. Klein, Lars Egevad, Samson W. Fine, Chandana A. Reddy, Misop Han
Publikováno v:
European Urology. 69:428-435
Despite revisions in 2005 and 2014, the Gleason prostate cancer (PCa) grading system still has major deficiencies. Combining of Gleason scores into a three-tiered grouping (6, 7, 8-10) is used most frequently for prognostic and therapeutic purposes.
Autor:
Michael H. Johnson, Misop Han, Elizabeth B. Humphreys, J. Tosoian, Debasish Sundi, Alan W. Partin, Elai Davicioni, Patrick C. Walsh, Bruce J. Trock, Ashley E. Ross, Edward M. Schaeffer, Mercedeh Ghadessi, Kasra Yousefi
Publikováno v:
European Urology. 69:496-504
Background Current guidelines suggest adjuvant radiation therapy for men with adverse pathologic features (APFs) at radical prostatectomy (RP). We examine at-risk men treated only with RP until the time of metastasis. Objective To evaluate whether cl
Autor:
Lucia L. Lam, Stephanie Glavaris, Christine Buerki, Luigi Marchionni, Helen L. Fedor, Michael H. Johnson, Stephania M. Bezerra, Kasra Yousefi, George J. Netto, Voleak Choeurng, Misop Han, Elai Davicioni, Alan W. Partin, Ashley E. Ross, Edward M. Schaeffer, Elizabeth B. Humphreys, Sheila F. Faraj, Nicholas Erho, Bruce J. Trock
Publikováno v:
European Urology. 69:157-165
Radical prostatectomy (RP) is a primary treatment option for men with intermediate- and high-risk prostate cancer. Although many are effectively cured with local therapy alone, these men are by definition at higher risk of adverse pathologic features
Publikováno v:
European Urology. 72:e11-e12
Autor:
Byong Chang Jeong, Misop Han, Zhaoyong Feng, Alan W. Partin, Elizabeth B. Humphreys, Jonathan I. Epstein, Patrick C. Walsh, Heather J. Chalfin, Seung Bae Lee, Bruce J. Trock
Publikováno v:
European urology. 67(2)
Subclassification of the extent of extraprostatic extension (EPE) in radical prostatectomy (RP) specimens may enhance prognostication for prostate cancer (PCa) patients. Yet optimal criteria for staging, validation within a large cohort, and long-ter